Where this fits: Gender-affirming hormone therapy creates pharmacokinetic challenges for lamotrigine that parallel the oral contraceptive interaction covered in the previous lesson. This lesson examines considerations specific to transgender and gender-diverse patients, the diagnostic challenges in LGBTQ+ populations where minority stress can mimic mood episodes, and the elevated prevalence data that make this a clinically common intersection.